Abstract
Tuberculosis (TB) kills more youth and adults than any other infectious disease in the world today. The emergence of new strains of Mycobacterium tuberculosis resistant to some or all current antituberculosis drugs is a serious and crescent problem. The resistance is often a corollary to HIV infection and drug-resistant TB is more difficult and more expensive to treat, besides to be more likely fatal. Thus, it is still necessary to search for new antimycobacterial agents. The identification of novel targets need the identification of biochemical pathways specific to mycobacteria and related organisms. Many unique metabolic processes occur during the biosynthesis of mycobacterial cell wall components. In this report, we examine one of these attractive targets for the rational design of new antituberculosis agents - the mycolic acids.
Current Drug Targets
Title: An Approach for the Rational Design of New Antituberculosis Agents
Volume: 2 Issue: 4
Author(s): K. F. M. Pasqualoto and E. I. Ferreira
Affiliation:
Abstract: Tuberculosis (TB) kills more youth and adults than any other infectious disease in the world today. The emergence of new strains of Mycobacterium tuberculosis resistant to some or all current antituberculosis drugs is a serious and crescent problem. The resistance is often a corollary to HIV infection and drug-resistant TB is more difficult and more expensive to treat, besides to be more likely fatal. Thus, it is still necessary to search for new antimycobacterial agents. The identification of novel targets need the identification of biochemical pathways specific to mycobacteria and related organisms. Many unique metabolic processes occur during the biosynthesis of mycobacterial cell wall components. In this report, we examine one of these attractive targets for the rational design of new antituberculosis agents - the mycolic acids.
Export Options
About this article
Cite this article as:
M. Pasqualoto F. K. and Ferreira I. E., An Approach for the Rational Design of New Antituberculosis Agents, Current Drug Targets 2001; 2 (4) . https://dx.doi.org/10.2174/1389450013348227
DOI https://dx.doi.org/10.2174/1389450013348227 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multiplication of <i>Mycobacterium tuberculosis</i> in Peripheral Blood of Mice and Effect of Anti-tubercular Drugs on Bacteremia
Letters in Drug Design & Discovery One-Pot Synthesis of 5-Unsubstituted-6-Aroyl[1,2,4]triazolo[1,5-a]pyrimidine Utilizing Biginelli-Like Multicomponent Reaction of Enaminones with 3-Amino-1,2,4- triazole as the Urea Component
Current Organic Synthesis Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease
Medicinal Chemistry Anti-Inflammatory Therapy in Uveitis
Recent Patents on Inflammation & Allergy Drug Discovery Primary Isolated Mediastinal Abscess Masquerading as Mediastinal Mass- A Needle did the Trick
Current Respiratory Medicine Reviews Radziszewski Reaction: An Elegant, Easy, Simple and Efficient Method to Synthesise Imidazoles
Current Organic Synthesis Subject Index to Volume 1
Letters in Drug Design & Discovery Antimicrobial Potentials, Phytochemical Screening and Determination of Bioactive Compounds from Three Indian Folk Medicinal Plants
Current Bioactive Compounds The -omics Era- Toward a Systems-Level Understanding of Streptomyces
Current Genomics Pharmacokinetic Properties and In Silico ADME Modeling in Drug Discovery
Medicinal Chemistry Clinical and Regulatory Status of Silymarin
Applied Drug Research, Clinical Trials and Regulatory Affairs Childhood Hospitalisations for Physical Disease and Risk of Mental Disorders During Adolescence and Early Adulthood
Adolescent Psychiatry Emergence in Pyrazolines: Synthetic and Biological Perspective
The Natural Products Journal Anti-Oxidative Stress and Beyond: Multiple Functions of the Protein Glutathionylation
Protein & Peptide Letters The Dark Side of Stem Cells: Triggering Cancer Progression by Cell Fusion
Current Molecular Medicine Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research The Role of Universal Stress Proteins in Bacterial Infections
Current Medicinal Chemistry Morpholine Based Diazenyl Chalcones: Synthesis, Antimicrobial Screening and Cytotoxicity Study
Anti-Cancer Agents in Medicinal Chemistry Pneumococcal Infections at Hajj: Current Knowledge Gaps
Infectious Disorders - Drug Targets